WASHINGTON — A Danish company has delivered the first 1 million doses of a next-generation smallpox vaccine to the U.S. national stockpile, a vaccine reserved for people with weakened immune systems.
The federal government has ordered 20 million doses of Bavarian Nordic's Imvamune, as part of the nation's preparations in case of a bioterrorist attack.
The government has long stockpiled smallpox vaccine against such a possibility. But the conventional vaccine, made with a live virus that's a relative of smallpox, isn't safe for people with weakened immune systems. Imvamune is made of a different strain of the virus, targeted for the immune-compromised because it cannot multiply in human cells.
Most Users Ever Online: 288
Currently Browsing this Page:
Guest Posters: 2
Newest Members:Alan, Lozen, James, fredalonsojones, Peds, Skip Marks, ivafifed, eaglegene, Scott, [email protected]
Administrators: John Greenewald: 635, blackvault: 1776